Víctor Hernando

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Calpain-Mediated Impairment of Na ⁺ /K ⁺ –ATPase Activity During Early Reperfusion Contributes to Cell Death After Myocardial Ischemia

Javier Inserte, David García‐Dorado, Víctor Hernando et al. · Circulation Research · 2005 · 137 citations

Delayed recovery of intracellular acidosis during reperfusion prevents calpain activation and determines protection in postconditioned myocardium

Javier Inserte, Ignasi Barba, Víctor Hernando et al. · Cardiovascular Research · 2008 · 115 citations

Calpain translocation and activation as pharmacological targets during myocardial ischemia/reperfusion

Víctor Hernando, Javier Inserte, Carmem Luíza Sartório et al. · Journal of Molecular and Cellular Cardiology · 2010 · 105 citations · Full text

Molecular Pharmacology, Cardiac Muscle, Molecular Physiology +9

Effect of acidic reperfusion on prolongation of intracellular acidosis and myocardial salvage

J INSERTE, Ignasi Barba, Víctor Hernando et al. · Cardiovascular Research · 2007 · 103 citations · Full text